Results 41 to 50 of about 33,214 (212)
Cystatin C for gentamicin dosing - a case study. [PDF]
The study aims to present a case study of a patient with supratherapeutic serum gentamicin concentration. An 83-year-old male was admitted to the Department of Internal Medicine for persistent loss of appetite, decompensated heart failure, and pneumonia.
Šálek T +3 more
europepmc +4 more sources
Impact of Growth Hormone on Cystatin C [PDF]
<b><i>Background:</i></b> Cystatin C (CysC) is an alternative marker to creatinine for estimation of the glomerular filtration rate (GFR). Hormones such as thyroid hormones and glucocorticoids are known to have an impact on CysC.
Sze, Lisa +5 more
openaire +3 more sources
Cystatin C is Associated With Plaque Phenotype and Plaque Burden
Background/Aims: The relationship between carotid artery plaque burden, phenotype and serum cystatin C at normal and impaired renal function is still unclear. Methods: Demographic characteristics, carotid ultrasonography and other relevant information of
Yufeng Wen +9 more
doaj +1 more source
Maternal Cystatin C Serum is Higher in Women with Severe Preeclampsia
Objective: To determine the comparison between maternal cystatin C serum in severe preeclampsia and normal pregnancy. Method: This was an observational study with cross sectional analytic approach. The subjects are sixty women with severe preeclampsia
Kurnia M. Isasari +3 more
doaj +1 more source
Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. [PDF]
Amyotrophic lateral sclerosis (ALS) is a fatal neurologic disease characterized by progressive motor neuron degeneration. Clinical disease management is hindered by both a lengthy diagnostic process and the absence of effective treatments.
Meghan E Wilson +3 more
doaj +1 more source
Introduction Estimation of the glomerular filtration rate (GFR) is essential for the evaluation of patients with kidney disease, and for treating patients with drugs that are eliminated from the circulation by the kidneys. Cystatin C has been shown to be
Karawajczyk Malgorzata +2 more
doaj +1 more source
Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study
BackgroundAccumulating evidence has suggested that cystatin C is associated with cognitive impairment in patients with neurodegenerative diseases. However, the association between cystatin C and cognitive decline in patients with multiple system atrophy (
Lingyu Zhang +12 more
doaj +1 more source
Objective. Cystatin C is a very potent inhibitor of cysteine proteinases and, it has been clinically applied as a sensitive marker in monitoring of renal and liver functions.
Mehmet Buyukberber, Dr. +7 more
doaj +1 more source
Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
Elevated serum levels of cystatin C are found to be related to poor outcome and metastatic potential of some malignant disorders. To evaluate the clinical prominence of serum cystatin C in diffuse large B-cell lymphoma (DLBCL), blood samples were ...
Nada E. Hammouda +3 more
doaj +1 more source
Biomarkers of Sarcopenia: Current Status and Future Perspectives
In this review, we summarize the various biomarkers discovered in recent years, including biochemical, imaging, and physical testing markers. We analyze their advantages and disadvantages and propose potential ways to improve the diagnostic accuracy of biomarkers, as well as future research directions.
Bijin Luo +6 more
wiley +1 more source

